Argenx
ARGX
#435
Rank
A$79.81 B
Marketcap
A$1,269
Share price
-0.55%
Change (1 day)
1.53%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report